Molina Healthcare (MOH)
(Delayed Data from NYSE)
$327.48 USD
-3.64 (-1.10%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$327.48 USD
-3.64 (-1.10%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth A Momentum B VGM
Zacks News
4 Healthcare Stocks Likely to Beat Estimates in Q4
by Zacks Equity Research
An aging population, prevalence of chronic health conditions and greater utilization of healthcare services should drive the industry's growth, partly offset by an increase in expenses.
Top Ranked Value Stocks to Buy for January 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 31st
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 earnings surge on the back of operating performance and strong growth across all core businesses.
HCA Healthcare's (HCA) Q4 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings rise on the back of robust same facility admissions.
Get Explosive Returns with the Filtered Zacks Rank 5 Strategy
by Benjamin Rains
Today we are going to show investors how to add two relatively simple filters to our Zacks Rank #1 criteria that narrows down the number of stocks and often increases its performance as well.
What's in the Cards for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is likely to gain from Q4 results on revenue and membership growth, partly offset by higher expenses.
The Zacks Analyst Blog Highlights: Archer Daniels Midland, Molina Healthcare, Eli Lilly, Spark Energy and Lamb Weston
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Archer Daniels Midland, Molina Healthcare, Eli Lilly, Spark Energy and Lamb Weston
Is a Beat in Store for HCA Healthcare (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is likely to gain from higher admissions in Q4 earnings.
What Makes Molina (MOH) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Molina (MOH) have what it takes to be a top stock pick for momentum investors? Let's find out.
MOH vs. JYNT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
6 Stocks to Prepare for a Global Economic Slowdown
by Swarup Gupta
A slowdown in Europe and the ongoing trade conflicts have been cited as the major reasons for the IMF's projection cuts.
Will Molina Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Molina Healthcare, Inc (MOH).
Molina (MOH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Molina (MOH) closed at $137.13 in the latest trading session, marking a +1.28% move from the prior day.
Will Molina (MOH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Weakness Seen in Select Medical Holdings (SEM) Estimates: Should You Stay Away?
by Zacks Equity Research
Select Medical Holdings (SEM) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
DXC Technology to Buy Luxoft to Expand Digital Business
by Zacks Equity Research
DXC Technology (DXC) aims to expedite the digital transformation journey across its clients and strengthen Digital Solutions business with the acquisition of Luxoft.
Molina Healthcare (MOH) in Focus: Stock Moves 7.4% Higher
by Zacks Equity Research
Molina Healthcare (MOH) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Molina Renews Pact With CVS to Boost PBM Service Platform
by Zacks Equity Research
Molina (MOH) expands deal with CVS Caremark for Pharmacy Benefit Management services.
Ensign Group's (ENSG) Buyout to Expand Business in Utah
by Zacks Equity Research
Ensign Group (ENSG) acquires the real estate and operations of Bella Terra Cedar City to bolster its growth profile.
Anthem or Humana: Which HMO Stock is a Better Buy for 2019?
by Zacks Equity Research
The health insurance industry is poised for growth despite some policy disturbances; here we analyze which stock Anthem or Humana would provide greater returns in 2019.
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet (THC) Signs Deal to Provide Services to Cigna Members
by Zacks Equity Research
Tenet (THC) enters new agreements to provide in-network access to Cigna members
Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
by Zacks Equity Research
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare